News

  • Crossject - AFPric study: patients approve needle-free injection

    Crossject and AFPric, the largest French association of patients with polyarthritis and chronic inflammatory rheumatisms, pursued their collaboration and released today the main findings of a study conducted with members of AFPric on their treatment and their interest in needle-free injection. 

    The study reveals that patients with rheumatoid polyarthritis are largely prepared to use needle-free injection as part of their treatment. 85.9% of respondents are ready to use a needle-free injection device, three quarters of which are currently taking their treatment with injection 

    Read the press release

    Read more
  • CROSSJECT signs a partnership agreement for ZENEO® Methotrexate in China

    CROSSJECT has completed a non-exclusive partnership agreement in China with Xi'an Xiantong Pharmaceutical Research to promote and sale ZENEO® Methotrexate. The agreement with this well-established player in its domestic market allows to estimate a turnover of around € 360 million generated by royalties for ZENEO® Methotrexate over 10 years according to the terms of the contract, to which the profits from the supply contract will be added. "By positioning ZENEO® Methotrexate on a fast growing market potentially representing very big volumes for our drugs, we are in perfect conditions to create value for CROSSJECT and their shareholders," said Patrick Alexandre, President and founder of CROSSJECT. 

    Read more

Events

  • 07/01/2016

    Crossject will be present at BioPharm America 2016

    Crossject will be present at BIOPHARM AMERICA 2016, the 9th Annual International Partnering Conference, September 13 to 15. BIOPharm America™ is where biotech industry partnerships get started, with biotech and pharma executives from around the world. Close to 900 attendees are expected to participate in this Conference.
    Contact Tim Muller: tm@scientex.eu or  t.muller@crossject.com  / Mobile +33 (0)645523540 / skype id: timotheemuller

    Read more
  • 08/01/2014

    Crossject will be present at EuroPLX 62 Nice

    Meet us in Nice, November 21th and 22nd, during the Pharma Event EuroPLX.
    Contact Tim Muller: tm@scientex.eu or  t.muller@crossject.com  / Mobile +33 (0)645523540 / skype id: timotheemuller

    Read more

video

Discover our needle-free self injectable solution

The desire for safer and more user-friendly injection device to prevent needle-stick injuries...

more videos